NO900427L - Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling. - Google Patents

Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling.

Info

Publication number
NO900427L
NO900427L NO90900427A NO900427A NO900427L NO 900427 L NO900427 L NO 900427L NO 90900427 A NO90900427 A NO 90900427A NO 900427 A NO900427 A NO 900427A NO 900427 L NO900427 L NO 900427L
Authority
NO
Norway
Prior art keywords
preparation
erosion
active agent
active agents
resolution
Prior art date
Application number
NO90900427A
Other languages
English (en)
Other versions
NO900427D0 (no
Inventor
Udo Wenzel
Juergen Metzner
Horst Nindel
Halvor Jaeger
Zoser B Salama
Original Assignee
Int Pharma Agentur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD32535389A external-priority patent/DD295759A5/de
Priority claimed from DE19893933000 external-priority patent/DE3933000A1/de
Application filed by Int Pharma Agentur filed Critical Int Pharma Agentur
Publication of NO900427D0 publication Critical patent/NO900427D0/no
Publication of NO900427L publication Critical patent/NO900427L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Sorption Type Refrigeration Machines (AREA)

Abstract

Oppfinnelsen vedrorer et system til fortrinnsvis peroral administrering med erosjonsregulert aktivt middelfrlgjørlng og en fremgangsmåte for dens fremstil- ling som fortrinnsvis lavoppløsellge aktive midler blir frigjort med forsinkelse, og 1 en mulig kombinasjon av hensiktsmessige, høyoppløselige aktive midler blir sistnevnte frigjort raskt og med bare liten for- sinkelse. Det aktive mldlet(ene) blir fremstilt på en vanlig måte med hjelpestoffer som har evne til Evelling, f.eks. mikrokrystallinsk cellulose eller stivelse, med hjelpestoffer som har høyere affinitet til vann og fungerer som svelleregulatorer (f.eks. polyetylenglykoler, sterkt hydratlserende uorganiske forbindelser) og valgfritt med ytterligere hjelpe- stoffer. De farmasøytiske fremstillingene fremstilt på denne måten bidrar betydelig i å forbedre terapien med forskjellige sykdommer, for når passende og fortrinns- vis lavoppløsellge aktive midler blir inkorporert, blir Justering og opprettholdelse av terapeutisk effektive konsentrasjoner med aktivt middel sikret.
NO90900427A 1989-01-31 1990-01-30 Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling. NO900427L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD32535389A DD295759A5 (de) 1989-01-31 1989-01-31 Erosionsgesteuertes arzneistofffreigabesystem und verfahren zu seiner herstellung
DE19893933000 DE3933000A1 (de) 1989-10-03 1989-10-03 Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
NO900427D0 NO900427D0 (no) 1990-01-30
NO900427L true NO900427L (no) 1990-08-01

Family

ID=25748260

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900427A NO900427L (no) 1989-01-31 1990-01-30 Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling.

Country Status (15)

Country Link
EP (1) EP0381182B1 (no)
JP (1) JPH02282322A (no)
KR (2) KR900011455A (no)
AT (1) ATE125698T1 (no)
AU (1) AU637782B2 (no)
CA (1) CA2009044A1 (no)
DE (1) DE69021224T2 (no)
DK (1) DK0381182T3 (no)
ES (1) ES2078252T3 (no)
FI (1) FI900469A7 (no)
GR (1) GR3017785T3 (no)
HU (1) HU205850B (no)
IE (1) IE69555B1 (no)
NO (1) NO900427L (no)
RU (1) RU2079301C1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
CN1143680C (zh) * 1997-08-14 2004-03-31 阿旺蒂斯制药公司 增强非索非那定及其衍生物之生物利用度的方法
ES2226886T3 (es) * 1999-08-31 2005-04-01 Grunenthal Gmbh Forma de administracion de accion retardada que contiene sacarinato de tramadol.
RU2203062C2 (ru) * 2000-10-13 2003-04-27 Закрытое акционерное общество "ФАРМАПЭК" Бронхолитическое средство и способ его получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055930A1 (de) * 1970-11-13 1972-05-18 Boehringer Mannheim Gmbh, 6800 Mannheim Verbesserte orale Applikationsform von Raubasin
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition

Also Published As

Publication number Publication date
DK0381182T3 (da) 1995-10-30
KR900011455A (ko) 1990-08-01
IE900335L (en) 1990-07-31
NO900427D0 (no) 1990-01-30
KR910007515A (ko) 1991-05-30
FI900469A0 (fi) 1990-01-30
DE69021224D1 (de) 1995-09-07
AU4898790A (en) 1990-08-09
ATE125698T1 (de) 1995-08-15
ES2078252T3 (es) 1995-12-16
EP0381182B1 (en) 1995-08-02
CA2009044A1 (en) 1990-07-31
HU205850B (en) 1992-07-28
GR3017785T3 (en) 1996-01-31
RU2079301C1 (ru) 1997-05-20
AU637782B2 (en) 1993-06-10
EP0381182A2 (en) 1990-08-08
JPH02282322A (ja) 1990-11-19
EP0381182A3 (en) 1991-01-09
FI900469A7 (fi) 1990-08-01
DE69021224T2 (de) 1996-04-04
IE69555B1 (en) 1996-10-02

Similar Documents

Publication Publication Date Title
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
NO971361L (no) Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
BRPI0012352B8 (pt) compostos de indazol ou sal farmaceuticamente aceitável e composição farmacêutica
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
ATE186462T1 (de) Gepirone enthaltende zusammensetzungen
CA2378918A1 (en) Method of treating symptoms of hormonal variation, including hot flashes
CA2321560A1 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
NO900427L (no) Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling.
SE8901003D0 (sv) Snabbloesliga preparat
BG103512A (en) Substituted pyramidine compounds and their application
Fuhrman et al. Early changes in distribution of sodium, potassium and water in rabbit muscles following release of tourniquets
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
BR0313503A (pt) Método de tratamento de sìndrome das pernas inquietas, uso do antagonista de receptor da adenoina a2a, agente terapêutico para sìndrome das pernas inquietas, e, método de tratamento da mioclonia noturna
US5026706A (en) Method for treating dysuria using naftopidil
KR20020089399A (ko) 세로토너직 계와 관련된 질병의 치료
US4534973A (en) Pharmaceutical compositions
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
CA2532330A1 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
SE9502877D0 (sv) Novel opioid peptides